AI startup Inceptive recently secured $100 million in Series A funding, with investors including NVIDIA. Founded by Transformer paper author Jakob Uszkoreit and others, the company designs mRNA molecule sequences through its machine learning platform, significantly reducing drug development cycles. It has partnered with major European pharmaceutical companies to co-develop mRNA vaccines. Technological advancements are expected to reach a turning point within three years, with RNA therapy leading the way.